IBM Rational ClearQuest 7.0.1 Login Page script information disclosure
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.8 | $0-$5k | 0.00 |
Summary
A vulnerability labeled as problematic has been found in IBM Rational ClearQuest 7.0.1. Affected is an unknown function of the component Login Page. Such manipulation of the argument script leads to information disclosure. This vulnerability is uniquely identified as CVE-2008-3550. The attack can be launched remotely. No exploit exists. Applying a patch is advised to resolve this issue.
Details
A vulnerability was found in IBM Rational ClearQuest 7.0.1 (Business Process Management Software) and classified as problematic. Affected by this issue is an unknown part of the component Login Page. The manipulation of the argument script with an unknown input leads to a information disclosure vulnerability. Using CWE to declare the problem leads to CWE-200. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information. Impacted is confidentiality. CVE summarizes:
The CQWeb login page in IBM Rational ClearQuest 7.0.1 allows remote attackers to obtain potentially sensitive information (page source code) via a combination of ?script? and ?/script? sequences in the id field, possibly related to a cross-site scripting (XSS) vulnerability.
The weakness was disclosed 08/08/2008 (Website). The advisory is shared for download at www-1.ibm.com. This vulnerability is handled as CVE-2008-3550 since 08/08/2008. The exploitation is known to be easy. The attack may be launched remotely. No form of authentication is required for exploitation. Successful exploitation requires user interaction by the victim. There are known technical details, but no exploit is available. The MITRE ATT&CK project declares the attack technique as T1592.
It is declared as proof-of-concept.
Applying a patch is able to eliminate this problem.
The vulnerability is also documented in the databases at X-Force (44254) and SecurityTracker (ID 1020642†). VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 3.8
VulDB Base Score: 4.3
VulDB Temp Score: 3.8
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Information disclosureCWE: CWE-200 / CWE-284 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Proof-of-Concept
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: PatchStatus: 🔍
0-Day Time: 🔍
Timeline
08/07/2008 🔍08/08/2008 🔍
08/08/2008 🔍
08/08/2008 🔍
03/17/2015 🔍
11/22/2017 🔍
Sources
Vendor: ibm.comAdvisory: www-1.ibm.com
Status: Confirmed
CVE: CVE-2008-3550 (🔍)
GCVE (CVE): GCVE-0-2008-3550
GCVE (VulDB): GCVE-100-43592
X-Force: 44254 - IBM Rational ClearQuest login page information disclosure
SecurityTracker: 1020642
Vupen: ADV-2008-2317
Entry
Created: 03/17/2015 12:19Updated: 11/22/2017 08:22
Changes: 03/17/2015 12:19 (52), 11/22/2017 08:22 (6)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.